Literature DB >> 23786680

Rules of thumb for maximum percent tumor accumulation.

Guozheng Liu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23786680      PMCID： PMC4014140          DOI： 10.1016/j.nucmedbio.2013.04.010

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN： 0969-8051            Impact factor:   2.408


× No keyword cloud information.
  12 in total

1.  Pharmacokinetic analysis of two-step approaches using bifunctional and enzyme-conjugated antibodies.

Authors:  F Yuan; L T Baxter; R K Jain
Journal:  Cancer Res       Date:  1991-06-15       Impact factor: 12.701

2.  Antibody-dependent signal amplification in tumor xenografts after pretreatment with biotinylated monoclonal antibody and avidin or streptavidin.

Authors:  A I Kassis; P L Jones; K Z Matalka; S J Adelstein
Journal:  J Nucl Med       Date:  1996-02       Impact factor: 10.057

3.  Tumor pretargeting in mice using (99m)Tc-labeled morpholino, a DNA analog.

Authors:  Guozheng Liu; Kennedy Mang'era; Ning Liu; Suresh Gupta; Mary Rusckowski; Donald J Hnatowich
Journal:  J Nucl Med       Date:  2002-03       Impact factor: 10.057

4.  Further investigations of morpholino pretargeting in mice--establishing quantitative relations in tumor.

Authors:  Guozheng Liu; Jiang He; Shuping Dou; Suresh Gupta; Mary Rusckowski; Donald J Hnatowich
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-09       Impact factor: 9.236

5.  Pharmacokinetic comparison of direct antibody targeting with pretargeting protocols based on streptavidin-biotin binding.

Authors:  C Sung; W W van Osdol
Journal:  J Nucl Med       Date:  1995-05       Impact factor: 10.057

6.  Tumor pretargeting: almost the bottom line.

Authors:  D A Goodwin
Journal:  J Nucl Med       Date:  1995-05       Impact factor: 10.057

7.  Tumor pretargeting in mice using MORF conjugated CC49 antibody and radiolabeled complimentary cMORF effector.

Authors:  G Liu; S Dou; P H Pretorius; X Liu; L Chen; M Rusckowski; D J Hnatowich
Journal:  Q J Nucl Med Mol Imaging       Date:  2009-12-15       Impact factor: 2.346

8.  An experimental and theoretical evaluation of the influence of pretargeting antibody on the tumor accumulation of effector.

Authors:  Guozheng Liu; Shuping Dou; Mary Rusckowski; Donald J Hnatowich
Journal:  Mol Cancer Ther       Date:  2008-05       Impact factor: 6.261

9.  The ratio of maximum percent tumour accumulations of the pretargeting agent and the radiolabelled effector is independent of tumour size.

Authors:  Guozheng Liu; Shuping Dou; Minmin Liang; Xiangji Chen; Mary Rusckowski; Donald J Hnatowich
Journal:  Eur J Cancer       Date:  2009-10-05       Impact factor: 9.162

10.  Amplification targeting: a modified pretargeting approach with potential for signal amplification-proof of a concept.

Authors:  Jiang He; Guozheng Liu; Suresh Gupta; Yumin Zhang; Mary Rusckowski; Donald J Hnatowich
Journal:  J Nucl Med       Date:  2004-06       Impact factor: 10.057
View more
  1 in total

1.  Comparison between two labeled agents in mice using a coinjection-ratio approach in contrast to a conventional group approach.

Authors:  Shuping Dou; Yuzhen Wang; Bruce Barton; Ling Chen; Mary Rusckowski; Leonard D Shultz; Dale L Greiner; Guozheng Liu
Journal:  Nucl Med Biol       Date:  2013-10-09       Impact factor: 2.408
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.